The Future of Medicine
Our vision is to continue to drive the development and accelerate the delivery of world-leading gene and gene-modified cell therapies to improve the health of all Australians.
Latest News
New research facility to deliver life-saving medical technology in Western Sydney
CMRI is delighted by the NSW Government’s announcement about the establishment of Australia’s first commercial-scale viral vector manufacturing facility in the Westmead Health and Innovation District. The ability to manufacture high-quality (clinical grade) viral vectors in Australia is critically important for our gene therapy programs. It will accelerate the delivery of, and access to, life-saving new gene therapies developed in the CMRI labsContinue reading “New research facility to deliver life-saving medical technology in Western Sydney”
Research Collaboration Announced Between CMRI and DiNAQOR to Develop Novel, Cardiac Specific Capsids
CMRI has entered into a research collaboration with Zurich-based DiNAQOR, a genetic medicine platform company, to develop capsid gene therapy tools for treatment of both cardiovascular and kidney diseases.
Australian first gene therapy for childhood blindness
Two Sydney siblings have become the first patients in the country to receive a novel gene therapy that has rescued their vision and holds hope for preventing them from going blind. The ocular gene therapy, LUXTURNA, is the world’s first approved gene replacement therapy for an inherited blinding eye condition and one of the firstContinue reading “Australian first gene therapy for childhood blindness”
Get new content delivered directly to your inbox.
Australian Genome Therapeutics Centre is a joint initiative of
